AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33104504 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferred ankle angle during ramp ascent
Number of subjects: 7
Study 33104504 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferred ankle angle during ramp descent
Number of subjects: 7
Study 33104504 — intervention group
Group type: EXPERIMENTAL
Intervention: Response rate to preferred alignment during level-ground walking
Number of subjects: 7
Study 33104504 — intervention group
Group type: EXPERIMENTAL
Intervention: Socket pressures and tibial progression during ramp walking
Number of subjects: 7
Study 33010934 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125 mg of palonosetron (Group 1)
Number of subjects: 60
Study 33010934 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg of ondansetron associated with 4 mg of dexamethasone (Group 2)
Number of subjects: 60
Study 33010934 — intervention group
Group type: COMPARATOR
Intervention: 4 mg of dexamethasone (Group 3)
Number of subjects: 60
Study 35442963 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT intervention
Number of subjects: 98
Study 35442963 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 98
Study 34509736 — intervention group
Group type: EXPERIMENTAL
Intervention: Unplugged program
Number of subjects: 2685
Study 34509736 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2685
Study 32507057 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinomed orthosis
Number of subjects: 44
Study 36443585 — intervention group
Group type: EXPERIMENTAL
Intervention: Phloroglucinol (oral or IV/IM)
Number of subjects: 364
Study 36443585 — intervention group
Group type: COMPARATOR
Intervention: Reference drug (dexketoprofen for urinary spasms and pain; metamizole or scopolamine for biliary colic)
Number of subjects: 364
Study 32844557 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 17200
Study 32844557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17200
Study 32147654 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention using mobile technology plus usual care
Number of subjects: 0
Study 32147654 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 0
Study 35770295 — intervention group
Group type: EXPERIMENTAL
Intervention: CCRT with docetaxel plus cisplatin (DP)
Number of subjects: 125
Study 35770295 — intervention group
Group type: EXPERIMENTAL
Intervention: CCRT with docetaxel (D)
Number of subjects: 125
Study 35770295 — intervention group
Group type: EXPERIMENTAL
Intervention: CCRT with cisplatin (P)
Number of subjects: 125
Study 34154666 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard EMOTION intervention delivered in 16 group-based sessions
Number of subjects: 40
Study 34154666 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially-digital EMOTION intervention delivered as eight group sessions and eight digital sessions
Number of subjects: 40
Study 34154666 — intervention group
Group type: EXPERIMENTAL
Intervention: High involvement with parent participation in a 5-session parent group
Number of subjects: 40
Study 34154666 — intervention group
Group type: COMPARATOR
Intervention: Low involvement sharing information with parents via a brochure
Number of subjects: 40
Study 34154666 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement and feedback system (MFS) for group leaders
Number of subjects: 40
Study 34154666 — intervention group
Group type: COMPARATOR
Intervention: No measurement and feedback system (no MFS)
Number of subjects: 40
Study 34154666 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report questionnaires pre-, post-, and one year after intervention
Number of subjects: 40
Study 36484189 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic qi acupuncture with needle retention for 10 min (observation group A)
Number of subjects: 160
Study 36484189 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic qi acupuncture with needle retention for 20 min (observation group B)
Number of subjects: 160
Study 36484189 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic qi acupuncture with needle retention for 30 min (observation group C)
Number of subjects: 160
Study 36484189 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib capsules, 0.2 g twice a day (medication group)
Number of subjects: 160
Study 34287900 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 38
Study 34287900 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study 33009349 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (350 mg·d ‐1 , 10 days)
Number of subjects: 22
Study 33009349 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium supplementation
Number of subjects: 22
Study 33009349 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pla)
Number of subjects: 22
Study 32268942 — intervention group
Group type: EXPERIMENTAL
Intervention: BP‐SES (biodegradable polymer sirolimus‐eluting stent)
Number of subjects: 440
Study 32268942 — intervention group
Group type: COMPARATOR
Intervention: DP‐EES (durable polymer everolimus‐eluting stent)
Number of subjects: 440
Study 32268942 — intervention group
Group type: EXPERIMENTAL
Intervention: BP‐SES
Number of subjects: 440
Study 32268942 — intervention group
Group type: COMPARATOR
Intervention: DP‐EES
Number of subjects: 440
Study 33407132 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRs generated from RNA-sequencing analysis, with 96 pairs of primers selected for testing.
Number of subjects: 79
Study 33407132 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of genetic diversity metrics based on SSRs.
Number of subjects: 79
Study 33407132 — intervention group
Group type: EXPERIMENTAL
Intervention: NJ clustering and UPGMA/PCoA analysis.
Number of subjects: 79
Study 33407132 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of molecular variance (AMOVA).
Number of subjects: 79
Study 33407132 — intervention group
Group type: EXPERIMENTAL
Intervention: Development of fingerprints for 79 Carex species.
Number of subjects: 79
Study 33212488 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab
Number of subjects: 30
Study 33260442 — intervention group
Group type: EXPERIMENTAL
Intervention: Children cared for by non-Latino providers
Number of subjects: 120
Study 33260442 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with Latino providers
Number of subjects: 120
Study 33378247 — intervention group
Group type: EXPERIMENTAL
Intervention: Intelligent personal assistants (IPAs) provided to individuals with ID
Number of subjects: 22
Study 33622396 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled individual participant data (IPD) from randomised controlled trials (RCTs) conducted in adult care homes
Number of subjects: 418000
Study 33622396 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled IPD
Number of subjects: 418000
Study 33622396 — intervention group
Group type: EXPERIMENTAL
Intervention: Key resident characteristics and outcomes identified from trial repository
Number of subjects: 418000
Study 32586100 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniotomy-high H19 group
Number of subjects: 264
Study 32586100 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniotomy-low H19 group
Number of subjects: 264
Study 32586100 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic keyhole surgery (low H19)
Number of subjects: 264
Study 32586100 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic keyhole surgery (high H19)
Number of subjects: 264
Study 35075671 — intervention group
Group type: EXPERIMENTAL
Intervention: Jump to Reference (J2R)
Number of subjects: 0
Study 35075671 — intervention group
Group type: EXPERIMENTAL
Intervention: Copy Reference (CR)
Number of subjects: 0
Study 35075671 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed reference-based imputation methods
Number of subjects: 0
Study 33091585 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk prediction algorithm combined with diagnostic testing (12-lead ECG and KardiaMobile device for home monitoring) for patients identified at highest risk (algorithm risk score ≥ 7.4%)
Number of subjects: 0
Study 33091585 — intervention group
Group type: COMPARATOR
Intervention: Routine management (Control)
Number of subjects: 0
Study 33771903 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-DOTATATE
Number of subjects: 231
Study 33771903 — intervention group
Group type: COMPARATOR
Intervention: high-dose octreotide LAR
Number of subjects: 231
Study 32800482 — intervention group
Group type: EXPERIMENTAL
Intervention: Double faced tubularized preputial flap technique (group A)
Number of subjects: 160
Study 32800482 — intervention group
Group type: COMPARATOR
Intervention: Standard ventral preputial tubularized flap technique (group B)
Number of subjects: 160
Study 32800482 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 160
Study 34125503 — intervention group
Group type: EXPERIMENTAL
Intervention: HDx
Number of subjects: 43
Study 34125503 — intervention group
Group type: COMPARATOR
Intervention: HDF
Number of subjects: 43
Study 34630155 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT) for 12 weeks on a bicycle ergometer combined with strength training
Number of subjects: 86
Study 34630155 — intervention group
Group type: COMPARATOR
Intervention: Moderate Continuous Training (MCT) for 12 weeks combined with strength training
Number of subjects: 86
Study 36322510 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-peer tutors
Number of subjects: 32
Study 36322510 — intervention group
Group type: EXPERIMENTAL
Intervention: Faculty tutors
Number of subjects: 32
Study 36322510 — intervention group
Group type: COMPARATOR
Intervention: All tutors (near-peer and faculty)
Number of subjects: 32
Study 32323462 — intervention group
Group type: EXPERIMENTAL
Intervention: Peeling with 70% glycolic acid followed by 5% 5-fluorouracil cream
Number of subjects: 17
Study 32323462 — intervention group
Group type: COMPARATOR
Intervention: 5% 5-fluorouracil cream (twice daily)
Number of subjects: 17
Study 35686572 — intervention group
Group type: EXPERIMENTAL
Intervention: V-01 vaccine
Number of subjects: 10218
Study 35686572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10218
Study 34536716 — intervention group
Group type: EXPERIMENTAL
Intervention: Respecting the Circle of Life program (RCL)
Number of subjects: 534
Study 32232708 — intervention group
Group type: EXPERIMENTAL
Intervention: MMC trabeculectomy with intracameral tPA
Number of subjects: 16
Study 32232708 — intervention group
Group type: COMPARATOR
Intervention: MMC trabeculectomy
Number of subjects: 16
Study 34247582 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercises with elements of dance movement therapy (DMT), 30-min session, two times a week for 12 weeks
Number of subjects: 165
Study 34247582 — intervention group
Group type: COMPARATOR
Intervention: Basic exercise (BE), 30-min session, two times a week for 12 weeks
Number of subjects: 165
Study 34247582 — intervention group
Group type: COMPARATOR
Intervention: Usual care (CO)
Number of subjects: 165
Study 36096844 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of guidelines on Family Involvement
Number of subjects: 75
Study 33952427 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 0
Study 33952427 — intervention group
Group type: COMPARATOR
Intervention: Community weight management intervention
Number of subjects: 0
Study 35714630 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine specialty referral
Number of subjects: 1481
Study 35714630 — intervention group
Group type: COMPARATOR
Intervention: Primary care referral
Number of subjects: 1481
Study 33605029 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra (100 or 200 mg/day for 5 days)
Number of subjects: 165
Study 33605029 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone (40 mg in a single injection)
Number of subjects: 165
Study 33605029 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 165
Study 33605029 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone
Number of subjects: 165
Study 35949669 — intervention group
Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block (TAP)
Number of subjects: 80
Study 35949669 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block (QL)
Number of subjects: 80
Study 35949669 — intervention group
Group type: COMPARATOR
Intervention: Control group (no block)
Number of subjects: 80
Study 34776136 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam pad balance exercises (60 min/day, twice/week for 6 weeks)
Number of subjects: 30
Study 34776136 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 30
Study 32200815 — intervention group
Group type: EXPERIMENTAL
Intervention: I125 brachytherapy
Number of subjects: 638
Study 32200815 — intervention group
Group type: COMPARATOR
Intervention: Control group (enucleation)
Number of subjects: 638
Study 33974170 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS combined with conventional comprehensive treatment
Number of subjects: 40
Study 33974170 — intervention group
Group type: COMPARATOR
Intervention: Conventional comprehensive treatment
Number of subjects: 40
Study 34187533 — intervention group
Group type: EXPERIMENTAL
Intervention: Distributional approach for analysis of continuous outcomes
Number of subjects: 0
Study 34187533 — intervention group
Group type: COMPARATOR
Intervention: Fisher's exact test
Number of subjects: 0
Study 34187533 — intervention group
Group type: COMPARATOR
Intervention: 95% confidence interval for the difference in proportions
Number of subjects: 0
Study 36006613 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic-dose bodyweight-adjusted oral rivaroxaban (n=40)
Number of subjects: 56
Study 36006613 — intervention group
Group type: COMPARATOR
Intervention: Standard anticoagulation with heparins, with or without vitamin K antagonists (n=16)
Number of subjects: 56
Study 34275343 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) device
Number of subjects: 106
Study 34275343 — intervention group
Group type: COMPARATOR
Intervention: iPad group
Number of subjects: 106
Study 32859177 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care model
Number of subjects: 737
Study 35095084 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial combination therapy with ambrisentan and tadalafil
Number of subjects: 302
Study 36283254 — intervention group
Group type: EXPERIMENTAL
Intervention: Pingchan granule (PCG)
Number of subjects: 292
Study 36283254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292
Study 35265707 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural self-help intervention
Number of subjects: 77
Study 35265707 — intervention group
Group type: COMPARATOR
Intervention: Wait-list condition
Number of subjects: 77
Study 32314466 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen A (emollient-containing diaper with acidic, pH-buffered wipe)
Number of subjects: 0
Study 32314466 — intervention group
Group type: COMPARATOR
Intervention: Regimen B (non-emollient diaper and wipe with limited buffering capacity)
Number of subjects: 0
Study 35575751 — intervention group
Group type: COMPARATOR
Intervention: Sensor-augmented pump therapy
Number of subjects: 0
Study 33743017 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model based on relaxation maps
Number of subjects: 94
Study 33743017 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram
Number of subjects: 94
Study 33743017 — intervention group
Group type: COMPARATOR
Intervention: Radiomics signature
Number of subjects: 94
Study 33186396 — intervention group
Group type: EXPERIMENTAL
Intervention: exercise (participants anticipated and completed exercise)
Number of subjects: 31
Study 33186396 — intervention group
Group type: COMPARATOR
Intervention: anticipation (participants anticipated exercise but completed rest)
Number of subjects: 31
Study 33186396 — intervention group
Group type: COMPARATOR
Intervention: rest (participants anticipated and completed rest)
Number of subjects: 31
Study 34542654 — intervention group
Group type: EXPERIMENTAL
Intervention: Infection of retropharyngeal, pretracheal and carotid space, C-reactive protein and procalcitonin values
Number of subjects: 141
Study 34542654 — intervention group
Group type: EXPERIMENTAL
Intervention: Multispace neck infection
Number of subjects: 141
Study 32034016 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg orvepitant
Number of subjects: 44
Study 32034016 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg orvepitant
Number of subjects: 44
Study 32034016 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 32169030 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 206
Study 32169030 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 206
Study 35290819 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional reactivity
Number of subjects: 172
Study 35290819 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion regulation
Number of subjects: 172
Study 35290819 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsample analysis with anxiety disorder
Number of subjects: 172
Study 35290819 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsample analysis without anxiety disorder
Number of subjects: 172
Study 33957767 — intervention group
Group type: EXPERIMENTAL
Intervention: Tufts Be Well at Work
Number of subjects: 0
Study 33957767 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 32552782 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure pneumoperitoneum (8 mmHg) facilitated by deep neuromuscular blockade (post tetanic count of 1-2)
Number of subjects: 204
Study 32552782 — intervention group
Group type: COMPARATOR
Intervention: Normal-pressure pneumoperitoneum (12 mmHg) with moderate neuromuscular blockade (train-of-four response of 1-2)
Number of subjects: 204
Study 34704120 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-severe hypoglycaemic episodes (NSHEs) 2-11 per year
Number of subjects: 0
Study 34704120 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-severe hypoglycaemic episodes (NSHEs) ≥12 per year
Number of subjects: 0
Study 34635141 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinect-based Rapid Movement Training (RMT)
Number of subjects: 30
Study 34635141 — intervention group
Group type: COMPARATOR
Intervention: Conventional Balance Training (CBT)
Number of subjects: 30
Study 34635141 — intervention group
Group type: COMPARATOR
Intervention: Both groups (RMT and CBT)
Number of subjects: 30
Study 33030753 — intervention group
Group type: EXPERIMENTAL
Intervention: Reducing drinking (AUDIT < 8)
Number of subjects: 2003
Study 36108603 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthesia prior to mydriatic drops
Number of subjects: 66
Study 36108603 — intervention group
Group type: COMPARATOR
Intervention: Preservative-free artificial tear drops (Control)
Number of subjects: 66
Study 32138790 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovarian hyperstimulation syndrome (OHSS)
Number of subjects: 76
Study 32138790 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced ovarian cancer (OC)
Number of subjects: 76
Study 32138790 — intervention group
Group type: COMPARATOR
Intervention: Benign adnexal mass (BAM)
Number of subjects: 76
Study 32138790 — intervention group
Group type: COMPARATOR
Intervention: Ovarian endometriosis (EM)
Number of subjects: 76
Study 32957816 — intervention group
Group type: EXPERIMENTAL
Intervention: Preeclampsia group (8 women)
Number of subjects: 136
Study 32957816 — intervention group
Group type: COMPARATOR
Intervention: Control group (8 normotensive women)
Number of subjects: 136
Study 34606529 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous ketone supplement (β‐hydroxybutyrate)
Number of subjects: 18
Study 34606529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 35943847 — intervention group
Group type: EXPERIMENTAL
Intervention: Zentangle group (2-hr class and encouraged practice for 2 weeks)
Number of subjects: 38
Study 35943847 — intervention group
Group type: EXPERIMENTAL
Intervention: Zentangle practice for >80 min per week
Number of subjects: 38
Study 35943847 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 38
Study 33616836 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk prediction model for permanent congenital hypothyroidism (CH)
Number of subjects: 1047
Study 32664535 — intervention group
Group type: EXPERIMENTAL
Intervention: HVLA plus resistance exercise
Number of subjects: 31
Study 32664535 — intervention group
Group type: COMPARATOR
Intervention: Resistance exercise alone
Number of subjects: 31
Study 35686380 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib-tramadol co-crystal (CTC) 200 mg every 12 h
Number of subjects: 637
Study 35686380 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg every 6 h
Number of subjects: 637
Study 35686380 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 100 mg every 12 h
Number of subjects: 637
Study 35686380 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 637
Study 33605620 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized amikacin at a dose of 40 mg/kg/day for 3-5 days
Number of subjects: 0
Study 33605620 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized colistimethate sodium (CMS) at a dose of 15 million IU/day for 3-5 days
Number of subjects: 0
Study 33605620 — intervention group
Group type: COMPARATOR
Intervention: Intravenous administration of a new cephalosporine/ß-lactamase inhibitor for 7 days
Number of subjects: 0
Study 33605620 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized CMS at a dose of 15 million IU/day for VAP caused by pandrug-resistant GNB
Number of subjects: 0
Study 33605620 — intervention group
Group type: COMPARATOR
Intervention: Intravenous CMS at a dose of 9 million IU/day
Number of subjects: 0
Study 32741773 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg/day ubiquinol from 7 days before to 5 days after surgery
Number of subjects: 50
Study 32741773 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 34888277 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-wide mass drug administration (cMDA) for soil-transmitted helminths (STH) delivered by CDDs.
Number of subjects: 104
Study 32712307 — intervention group
Group type: EXPERIMENTAL
Intervention: 38% silver diamine fluoride (SDF) solution
Number of subjects: 194